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Abstract 
Group A Streptococcus (GAS) has long been recognized as a human pathogen causing an 
exceptionally broad range of infections. However, despite intense research, the molecular 
mechanisms of GAS disease remain unclear. Recently, many important discoveries have 
been made that shed light on GAS pathogenesis and open exciting new avenues for future 
research. Advances in genome sequencing, microarray technology and proteomic 
analysis in combination with the development of more suitable animal models have 
dramatically increased the amount of data regarding the mechanisms of GAS 
pathogenesis. The information gained from these studies will translate into the 
identification of improved diagnostics and new targets for novel therapeutic drugs and 
vaccines. 
 
Epidemiologic versatility of group A Streptococcus 
The Gram-positive bacterium Streptococcus pyogenes (group A Streptococcus, GAS) 
causes a range of human infections such as the clinically uncomplicated conditions 
pharyngitis (“strep throat”) and impetigo, whilst also causing severe invasive diseases 
including necrotizing fasciitis (NF, “flesh-eating disease”) and streptococcal toxic shock 
syndrome (STSS). In addition, the post-infection immune sequelae glomerulonephritis 
and acute rheumatic fever may occur. To cause such a wide spectrum of disease, GAS 
must be able to adapt to the diverse physiological conditions encountered in the human 
host. For example, the pathogen must overcome the first line of physical and immune 
defense in saliva to successfully colonize the oropharynx. Moreover, GAS must 
disseminate from the initial site of infection to cause invasive disease, a process which 
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requires the bacterium to break out of the local site of infection and survive in the blood. 
To accomplish each of these transitions, GAS has evolved sophisticated strategies and 
complex regulatory mechanisms that allow it to thwart host defenses and successfully 
colonize, thrive and/or persist in the host.  Many proven and putative virulence factors 
made by GAS contribute to host-pathogen interactions (Fig. 1). In this review, we discuss 
recent advances in the understanding of GAS pathogenesis and focus on the role of a 
variety of streptococcal virulence factors in the establishment and dissemination of 
disease. While the mechanistic basis of the regulation of many of these virulence factors 
is extremely important, a complete treatment of this topic is beyond the scope of this 
review. 
 
 
Survival of GAS in human saliva 
The oropharynx is the primary site of GAS entry into the human host. In this 
environment, GAS encounters saliva, which contains components of the innate and the 
acquired immune system including antimicrobial peptides that limit the growth of 
pathogenic bacteria. It has been known since the 1940s that saliva containing high levels 
of GAS plays a role in the person-to-person spread of this pathogen1-3. Recent in vitro 
analysis of the interaction between human saliva and GAS reveals that the microorganism 
has evolved a mechanism that allows it to persist in saliva at relatively high viable cell 
numbers for prolonged periods of time4. This phenomenon is specific for saliva, as GAS 
grown in either limited or defined liquid media did not remain viable for long time 
periods. It was also demonstrated that serotype M1 strains of GAS reach higher 
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concentrations in human saliva than strains of other serotypes. Considering that M1 
strains are a leading cause of streptococcal pharyngitis5, it may be that the relatively high 
density achieved in saliva by certain GAS serotypes enhances their likelihood of being 
transmitted to a new host.  
Shelburne et al.6 discovered that a two-component regulatory system of 
previously unknown function mediates the persistence of GAS in human saliva. This 
two-component system, designated sptR/S for saliva persistence, directly or indirectly 
controls expression of about 8% of the GAS genome in exponential growth phase and a 
striking 20% of the genome during stationary growth phase6. Of the genes controlled by 
sptR/S, genes involved in carbohydrate metabolism are most abundantly represented. One 
of the genes discovered to aid GAS survival in saliva is malE, which encodes a highly 
conserved maltodextrin-binding protein present in a broad range of GAS strains6,7. 
Several lines of evidence suggest that MalE is required for successful interaction of GAS 
with human saliva. Firstly, Shelburne et al.7 showed that an isogenic malE mutant is 
impaired in its ability to grow and persist in saliva in vitro compared to the parental GAS 
strain. These data imply that MalE may play a crucial role in the GAS-saliva interaction 
by contributing to nutrient acquisition. Since saliva contains only low levels of glucose, 
GAS depends on additional carbon sources for growth. One of the components found in 
saliva is amylase, which degrades ingested starch to smaller chains of carbohydrates. 
MalE may enable GAS to utilize these particular carbohydrates as additional energy 
sources. In addition, MalE may be essential for the earliest stages of GAS colonization as 
evidenced by high malE transcript levels early in the GAS-saliva interaction7. Thus, 
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human saliva may represent an important reservoir for GAS, which is critical for both 
persistence and transmission of the pathogen. 
 
Pharyngeal disease 
Although GAS is able to cause serious invasive disease, pharyngitis is by far the most 
common infection. For example, ~15 million cases of streptococcal pharyngitis occur 
annually in the US alone, resulting in an estimated 2 billion dollars of direct health care 
costs8. However, despite decades of research, our knowledge of the precise molecular 
events mediating GAS pharyngitis remains rudimentary. Recently, three strategies have 
been used to expand our understanding regarding the pathogenesis of this infection. One 
line of productive research that has yielded new information about GAS-host interactions 
has used mouse nasal-associated lymphoid tissue (NALT)9-11.  Use of NALT and a 
bioluminescent-tagged GAS strain has suggested that M cells in NALT transport GAS 
across the epithelial cell layer, perhaps facilitating invasion of deeper tissues9.  NALT 
also has been used to study immune responses to GAS10. 
 A second line of investigation has used gene transcript analysis of GAS in 
primary throat swabs obtained from patients with pharyngitis.  Virtaneva et al.12 used real 
time reverse-transcription PCR (RT-PCR) to study transcripts of 17 GAS genes in throat 
swab specimens obtained from 18 pediatric patients diagnosed with acute pharyngitis. 
This method allowed the analysis of GAS gene expression in vivo, thereby opening a new 
avenue of investigation. Genes belonging to two component regulatory systems, 
regulatory genes, and genes encoding proven and putative virulence factors were studied. 
Although the level of gene transcripts varied between individuals, several notable trends 
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emerged. For example, fasC, a gene encoding a member of a gene regulatory system, was 
highly expressed during acute pharyngitis. The fasBCA(X) regulates expression of 
fibronectin-binding proteins, superoxide dismutase, streptolysin S-associated genes, and 
streptokinase13. Another report suggested that the Fas regulon is upregulated under amino 
acid starvation, which may be encountered during initial contact of the pathogen with the 
skin and throat or at a site of high cell densities in a nidus of infection14. Virtaneva et al.12 
also showed that the mga (multi-gene activator) and perR regulatory genes were highly 
expressed during acute pharyngitis. Mga controls expression of genes encoding important 
GAS virulence factors including emm (M protein), mac (inhibitor of phagocytosis), and 
sic (streptococcal inhibitor of complement), all of which have been implicated in either 
adhesion to host cells or evasion from host defenses. Less is known about perR, although 
there is evidence that it plays a role in iron homeostasis and the oxidative stress response. 
It has been shown to be upregulated in vitro under iron-limiting conditions15, which GAS 
may encounter within the host during infection where most iron is sequestered by iron-
binding proteins and only minute amounts of free iron are available16. Of the 7 
extracellular proteins examined, 4 (scpA [C5a peptidase], bspA [cell surface protein], edin 
[homolog to Staphylococcus aureus EDIN toxin],and sda [DNase]) were upregulated 
during acute pharyngitis as determined by real-time RT-PCR12. 
 A third line of research has used a cynomolgus macaque model of pharyngitis 12, 
17-19. Due to high human host specificity of GAS, rodent models are inadequate in their 
representation of pharyngitis pathogenesis because they neither precisely mimic human 
GAS disease nor the host response against GAS infection.  Virtaneva et al.17 used 
expression microarray analysis to study longitudinal changes of GAS gene expression in 
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20 cynomolgus macaques experimentally infected with serotype M1 strain MGAS5005. 
This strain is genetically representative of M1 GAS strains which are currently 
responsible for a large percentage of pharyngitis and invasive infections20. The monkeys 
developed acute pharyngitis that was indistinguishable from human infection. This 
observation was noteworthy as other non-human primate models such as baboons21 and 
rhesus macaques22,23 can be successfully colonized with GAS in the upper respiratory 
tract but do not develop pharyngitis that mimics human disease. The discovery that 
cynomolgus macaques develop acute streptococcal pharyngitis that is a phenocopy of 
human disease has resulted in this animal model being treated as the gold standard for 
GAS pharyngitis studies. 
 Many pathogenic bacteria, including GAS, produce extracellular DNase, and it 
has been speculated that GAS DNase functions as a virulence factor. The contribution of 
a phage-encoded DNase to the pathogenesis of infection caused by contemporary M1 
strains has an interesting history that warrants brief review. In 1989, Stevens and 
colleagues24 observed that contemporary episodes of severe invasive GAS infections in 
the Rocky Mountain Region of the United States were associated with scarlet fever toxin 
A (SpeA), long known to be encoded by a bacteriophage. This crucial observation was 
confirmed by analyzing clonal diversity and genetic relationships among 108 strains of 
GAS recovered from patients throughout the USA25. Importantly, Southern blot analysis 
indicated that there were at least two distinct genotypes of serotype M1 strains, those that 
were speA-positive, and those that lacked this gene and presumably the bacteriophage 
encoding it. Further analysis revealed that contemporary serotype M1 isolates contained a 
distinct speA allele26. Cleary et al.27 confirmed the association of the speA gene with 
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severe serotype M1 GAS infections and extended the concept that two distinct subclones 
of serotype M1 existed. Importantly, the analysis revealed that relative to speA-negative 
strains, speA-positive strains contained approximately 70 kb of additional DNA. 
Subsequently, mouse virulence studies showed that speA-positive organisms were 
significantly more virulent28. A detailed genetic dissection of 126 GAS strains 
demonstrated considerable genetic diversity existed among M1 strains20. The analysis 
showed that a distinct virulent serotype M1 subclone had emerged recently and spread 
intercontinentally.  It was then discovered that some contemporary M1 isolates contain a 
gene encoding a DNase that is absent in the genome of strain SF37029. The DNase gene 
was linked to a phage gene, providing supportive evidence that contemporary serotype 
M1 strains were genetically distinct. Sumby et al.18 sequenced the genome of serotype 
M1 strain MGAS5005 and found that it had genes encoding three distinct DNases (spd3, 
sdaD2 and spd), two of which are bacteriophage-encoded.  Seven isogenic mutant strains 
were constructed and used to study the role of DNases in host-pathogen interactions in 
vivo18. Importantly, it was found that DNase production is required for normal 
progression of both pharyngitis and invasive infections. As part of the innate immune 
response to bacterial infection, neutrophils kill bacteria by entanglement in neutrophil 
extracellular traps, which consist of DNA and chromatin, and subsequent destruction of 
the captured pathogen30. Sumby et al.18 demonstrated that GAS DNase activity is crucial 
in assisting GAS to avoid destruction by neutrophils, which was confirmed by other 
investigators31. 
 Two additional recent publications have closed the loop on certain aspects of 
genetic differentiation of contemporary and old serotype M1 strains32,33. The occurrence 
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of prophages encoding DNases in contemporary M1 isolates was confirmed32. In 
addition, Sumby et al.33 sequenced the genome of a contemporary M1 strain and 
discovered that this speA-positive genotype originally described in 1991 had a 36-kb 
recombination region involving genes encoding several GAS toxins, including 
streptolysin O (SLO) and NAD+-glycohydrolase (NADase). Importantly, this 
recombination event is associated with significantly increased production of these two 
toxins. Sumby et al.33 used the genome sequence information, DNA-DNA microarray, 
high-throughput single nucleotide polymorphism analysis, and expression microarray 
analysis to reconstruct the molecular evolutionary events that resulted in the genesis of 
the abundant serotype M1 clone now responsible for much human disease worldwide. 
 
Vascular leakage and survival of GAS in plasma and blood 
When GAS causes superficial infections, it is exposed to human plasma at sites of 
inflammation as a consequence of vascular leakage, which is mediated in part by the 
interaction of M protein and fibrinogen with the β2-integrin adhesion molecule on the 
surface of neutrophils (PMNs). This complex results in a massive inflammatory response 
which involves the release of heparin binding protein (HBP) and induces vascular 
leakage34. As augmented vascular permeability is one of the underlying 
pathophysiological mechanism in shock, the crosslinking of the M protein and fibrinogen 
with β2-integrin may play an important role in the establishment of STSS. Plasma is a 
rich medium that supports bacterial growth, however it also contains many immune 
system components which GAS must elude to survive, including opsonizing antibodies 
and complement. Many plasma protein-GAS protein interactions interfere with the proper 
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function of host defenses5,35. Moreover, GAS expresses surface proteins that have a high 
affinity for several human plasma proteins such as albumin, fibrinogen, α2-
macroglobulin, IgG, and plasminogen5,35-38, which suggests that the pathogen has evolved 
mechanisms to capture and use host proteins for enhanced survival in vivo.  
To examine the effect of plasma on GAS protein expression, Johansson et al.39 
compared the proteomes of serotype M1 strain AP1 cultured in laboratory medium or in 
human plasma. Expression of 39 protein spots representing 24 unique GAS proteins, was 
significantly increased in cells cultured in human plasma. Interestingly, multiple spots for 
secreted extracellular proteins C5a peptidase and M1 were present in the proteome of 
plasma-grown bacteria, but were absent in the proteome of strain AP1 grown in 
laboratory medium. Concurrent with these data, a truncated variant of M1 protein lacking 
the N-terminal 13 amino acids of the mature, full-length protein was identified, a finding 
indicative of post-translational modification of this key virulence factor in response to 
plasma exposure39.  
We have only limited knowledge of changes in protein expression in GAS 
cultured in blood compared to laboratory media. However, Graham et al.40 have 
demonstrated that GAS undergoes a rapid and extensive remodeling of its transcriptome 
when grown in human blood ex vivo. Within 30 min after initial contact of GAS with 
whole blood, transcripts of 716 genes (representing 37% of the GAS genome) were up-
regulated whereas 425 transcripts (22% of the genome) were down-regulated. Transcripts 
of genes belonging to functional categories expected to be important for growth 
adaptation in blood including de novo synthesis of macromolecular precursors, 
carbohydrate metabolism, membrane transport, and transcriptional regulation were 
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increased. Expression of several virulence genes was up-regulated, including the 
multigene activator mga and its regulated transcripts emm1, sic, streptolysin, and has 
(capsular polysaccharide)40. Evidence for the up-regulation of capsule expression of GAS 
in blood in vivo was provided by Gryllos et al.41 who showed that there is a temporal 
relationship between capsule gene expression and proliferation of GAS in the blood of 
infected mice.  
 
Transition from local to systemic infection 
Each year GAS causes an estimated 700 million cases of mild non-invasive 
infections such as pharyngitis and impetigo worldwide. Approximately 700,000 of these 
develop into severe invasive disease42. The exact mechanism mediating the switch from a 
localized to a systemic infection remains to be elucidated. One factor that is thought to 
contribute to this process is the binding of GAS to human plasminogen and its subsequent 
activation to the broad-spectrum protease plasmin43-47. It was hypothesized that 
plasminogen is supplied by vascular leakage at the site of infection. There is evidence 
that GAS assembles a trimolecular complex consisting of fibrinogen, plasminogen, and 
streptokinase, which is associated with a propensity for invasive disease48,49. Recent 
studies using a humanized transgenic mouse model confirmed the important role for 
human plasminogen in the dissemination of GAS in vivo37,45 and lead to the proposal that 
GAS may subvert human plasminogen for use as a virulence factor36,45. Interestingly, 
GAS also produces the cysteine protease SpeB, which has been shown to directly degrade 
the trimolecular complex48. Differential regulation of speB expression seems to play a 
role in the transitioning from localized to invasive disease. The speB gene is found in 
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over 99% of GAS isolates and is highly conserved, and production of SpeB has been 
shown to be important in the establishment of localized GAS infections37,50,51. Kansal et 
al.52 observed that SpeB levels vary greatly in both clonally related and unrelated strains 
and that expression of SpeB and human invasive disease severity are inversely related in 
M1T1 GAS isolates.  In addition, passage of speB expressing GAS strains in mice 
resulted in a downregulation of speB concomitantly with the upregulation of M protein 
expression52. Moreover, Cole et al.37 discovered that there is a subpopulation of GAS in 
localized infections that can lose SpeB activity. This ultimately results in an 
accumulation of plasmin activity on the GAS cell surface and equips this particular 
subpopulation with enhanced invasive potential. Ultimately, this may result in the 
transition of GAS from the local site of infection to the blood and promotes dissemination 
to other parts of the host.   
 To gain additional information about the GAS genes expressed during skin and 
soft tissue infection, Graham et al.53 analyzed the transcriptome of GAS in mouse soft 
tissue infection.  The transcriptome of a serotype M1 strain was studied, and array 
datasets were verified by quantitative real-time RT-PCR and in situ 
immunohistochemistry.  The results demonstrated that coordinated expression of GAS 
virulence factors is directed toward overcoming innate host defenses, resulting in severe 
cellular damage.  In addition, several classes of genes were found to be highly expressed 
in vivo, including oxidative stress genes, virulence genes, genes related to complex 
carbohydrate utilization, and several two-component transcriptional regulators.  This 
study was the first global analysis of the GAS transcriptome in invasive infection and 
produced many new avenues for basic and translational research.    
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Severe invasive disease 
Severe invasive GAS infections have re-emerged on a global level since the mid-
1980s. These infections can progress rapidly and are associated with exceedingly high 
rates of morbidity and mortality54. Many strains causing necrotizing fasciitis, an 
especially severe and destructive infection, are serotype M1 and M3 strains54-56, which 
suggests that particular GAS strains have an increased propensity to cause invasive 
disease. 
Sumby et al.57 described two distinct transcriptome profiles of GAS that were 
linked to the type of disease, i.e. pharyngitis or invasive infection. The pharyngeal 
transcriptome profile (PTP) and the invasive transcriptome profile (ITP) differ 
significantly in expression of approximately 10% of the genome, including genes of 
several proven and putative virulence factors. Strains of the PTP were able to transition to 
the ITP phenotype during invasive infections, but strains of the ITP phenotype did not 
convert to the PTP phenotype under the conditions tested. Strains of the ITP phenotype 
were more resistant than PTP organisms to phagocytosis and killing by human 
neutrophils. To discover the genetic changes underlying the two distinct transcriptome 
profiles, complete genome re-sequencing of a mouse-derived ITP strain was conducted57. 
The genome of the ITP derivative organism differed from the PTP precursor strain by 
only a 7-bp frameshift mutation located in the covS gene, which encodes the sensor 
kinase of the CovR/S two-component regulatory system. CovR/S directly or indirectly 
controls approximately 15% of the GAS transcriptome58.   The frameshift mutation 
truncates CovS, resulting in the de-repression of many genes encoding proven virulence 
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factors, including speA (streptococcal pyrogenic exotoxin A), sagA (streptolysin S), mac, 
ska (streptokinase), and spd3. Consistent with these findings, Engleberg et al.59 reported 
that spontaneous mutations in CovR/S result in increased virulence in murine skin and 
soft tissue infections.  Thus, the transcriptome profile and the virulence character of GAS 
are intimately linked to the allelic state of the genes encoding the CovR/S two-component 
system. 
Several lines of evidence have recently implicated a GAS extracellular protease 
(termed ScpC or SpyCEP) that cleaves interleukin-8 (IL-8) in invasive disease60-62. IL-8 
is a chemoattractant that promotes recruitment of neutrophils to the site of infection by 
promoting their migration out of the bloodstream. Thus, the ability of GAS to impair the 
activity of IL-8 during infection may enhance its survival during infection and aid in its 
dissemination within the host. SpyCEP specifically cleaves the carboxy-terminus of IL-8, 
resulting in inactivation of the chemoattractant property of this molecule.  This enzyme 
also cleaves and inactivates mouse chemokines known as KC and MIP-262.  Hidalgo-
Grass et al.62 reported that inactivation of the gene encoding SpyCEP impairs GAS 
clearance from infected mouse tissue and is associated with decreased soft tissue 
infection.        
There is also evidence that mtsR, a gene encoding a metal transport regulator, may 
play a role in deep-muscle infections63-65. Using comparative genome re-sequencing, 
Beres et al.65 discovered that strains containing a naturally occurring mutation in mtsR, 
which yields a severely truncated MtsR protein, are significantly underrepresented among 
GAS isolates recovered from necrotizing fasciitis cases.  These results suggest that MtsR 
is necessary for the full virulence potential of GAS in invasive disease.  Expression 
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microarray analysis found that this truncation mutation is linked to significantly altered 
transcript levels of multiple genes and operons involved in metal homeostasis and 
response to oxidative stress65, which perhaps renders the pathogen more vulnerable to the 
host immune response. 
The molecular processes contributing to tissue destruction in GAS necrotizing 
fasciitis and myonecrosis remain poorly understood.  Recent studies have provided 
important evidence that streptolysin O-induced platelet/neutrophil complexes play a role 
in development of ischemic necrosis of tissue66.  In related work, Bryant et al.67 showed 
that an early step in the pathogenesis of GAS myonecrosis may involve binding of the 
pathogen to vimentin, a molecule that is up-regulated after skeletal-muscle injury.  
 
Asymptomatic carriage   
GAS is exclusively a human pathogen and therefore must survive in a human reservoir.  
Many individuals carry GAS asymptomatically in the upper respiratory tract and other 
anatomic sites. Over the years there have been several hypotheses to explain this 
phenomenon. In principle, asymptomatic carriage of GAS could arise as a consequence 
of mutations in the pathogen that down-regulate virulence, a productive immune response 
by the host that constrains pathogen proliferation, internalization into host cells, or some 
combination thereof.  Relatively little work has been done to study the genetic 
relationships between strains causing disease episodes and those of the same M protein 
serotype that are recovered from asymptomatic carriers.  However, this issue can now be 
studied at the genome-wide level.  To address this issue, Beres et al.68 used comparative 
genome re-sequencing to show that several serotype M3 strains from asymptomatic 
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throat carriers contained deletion mutations in the pleiotrophic virulence regulatory gene 
mga  and the emm gene.  The occurrence of these mutations in the carrier isolates but not 
in disease-causing organisms implicates them in down-regulating virulence.  Consistent 
with this idea, carrier strains were significantly less virulent, as assessed by 
intraperitoneal injection into mice68.  Thus, these data support the hypothesis that 
asymptomatic carriage may arise as a consequence of mutations that down-regulate 
virulence.    
While GAS has long been regarded as an extracellular pathogen, there has been 
evidence that it can invade non-phagocytic cells69-72. This observation has led to 
conjecture that internalization of GAS by host cells participates in the carrier state5,70,73.  
GAS internalization may allow the pathogen to evade certain host defenses and protect it 
from killing by antibiotics such as penicillin, as this antibiotic does not enter epithelial 
cells70. Consistent with this idea, Sela et al.70 observed that strains escaping antibiotic 
killing had significantly higher internalization efficiencies than strains that were 
successfully eliminated by antibiotic therapy. Other investigators have reported that 
genes encoding proteins that are linked to internalization, such as those encoding 
fibronectin-binding proteins F2, SfbI, and PfbpI, are significantly more prevalent among 
persisting GAS strains recovered from asymptomatic carriers5,73.  However, Brandt et 
al.74 found no evidence for an increased prevalence of the prtF1 gene among GAS 
isolates recovered from pharyngitis patients who had antibiotic treatment failure.  Hence, 
the literature bearing on this issue remains unclear and additional work is required to 
elucidate the role of host-cell internalization in asymptomatic carriage and other aspects 
GAS biology and pathogenesis.  
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Asymptomatic carriage of GAS also may have a role in some invasive infections. 
Medina and colleagues observed that the intracellular survival of GAS in neutrophils may 
result in increased bacterial virulence75. Using a mouse model, it was shown that ingested 
GAS is transported by neutrophils to distant parts of the body75. This is a notable finding 
as it may explain the cases of necrotizing fasciitis occurring in the absence of an entry 
wound or trauma adjacent to the site of GAS infection. 
 
Concluding remarks 
This review has highlighted some recent advances in our understanding of GAS 
pathogenesis and its interaction with the human host at various sites of infection. Many of 
the important findings have been made possible by contemporary genome sequencing, 
microarray technology and proteome analysis. Combined use of these technologies 
permits a global interrogation of molecular events that occur during host-pathogen 
interactions. Their use has revealed that GAS responds rapidly and in a regulated manner 
to the distinct environments encountered in the host during the establishment and 
dissemination of disease (Fig. 2). In the future, these approaches will be useful in 
identifying molecular markers specific for each phase of the disease process. This is 
especially important for severe invasive GAS diseases, which progress rapidly and are 
frequently diagnosed too late due to the current lack of appropriate diagnostics.  
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Box 1: Outstanding questions: 
 
What are the molecular markers in the initial stages of severe invasive diseases such as 
streptococcal toxic shock syndrome and necrotizing fasciitis? 
 
What is the molecular mechanism responsible for severe invasive GAS infections? 
 
What host factors are involved in the development of, as well as the susceptibility to, 
severe invasive disease? 
 
What is/are the environmental signal(s) that cause the transcriptional switch from non-
invasive to severe invasive streptococcal disease?  
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Figure Legends 
Figure 1: GAS virulence factors interact with the host at multiple levels. GAS has an 
arsenal of virulence factors at its disposal that allow it to successfully colonize and thrive 
in the host. At the cell and tissue level, these factors contribute to the pathogenicity of 
GAS by mediating adherence to host cells, by promoting internalization and invasion, 
and by evading phagocytosis. At the organism level, the virulence factors are involved in 
facilitating dissemination throughout the host and can induce systemic toxicity.  
Importantly, many of the proven streptococcal virulence factors function at multiple 
stages of infection. 
 
Figure 2: Group A Streptococcus modifies the transcription of genes belonging to 
diverse functional groups during infection. GAS causes many different human 
infections, reflecting its ability to adapt to diverse physiological conditions.  Several 
recent studies have investigated GAS transcriptome remodeling in pharyngitis17] and 
invasive soft-tissue infection53, and during growth in saliva6 and blood40. 
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Figure 2: Group A Streptococcus Modifies transcription of genes belonging to diverse functional
categories during infection.
